These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11196208)

  • 1. [Treatment of experimental corneal injuries by dioxidine and urotropin solutions].
    Musaev PI; Mamedov LA; Karaeva GZ
    Vestn Oftalmol; 2000; 116(6):20-3. PubMed ID: 11196208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic effects of the fluoroquinolone ofloxacin on stromal keratocytes.
    Oguz H
    Cornea; 2007 Feb; 26(2):241; author reply 241. PubMed ID: 17251826
    [No Abstract]   [Full Text] [Related]  

  • 4. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal pathogenesis of Staphylococcus aureus strain Newman.
    Dajcs JJ; Austin MS; Sloop GD; Moreau JM; Hume EB; Thompson HW; McAleese FM; Foster TJ; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1109-15. PubMed ID: 11923253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial keratitis following laser in situ keratomileusis for hyperopia.
    al-Reefy M
    J Refract Surg; 1999; 15(2 Suppl):216-7. PubMed ID: 10202724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of anti-inflammatory and anti-virulence effects of azithromycin in the treatment of experimental Staphylococcus aureus keratitis.
    Ikemoto K; Kobayashi S; Haranosono Y; Kozai S; Wada T; Tokushige H; Kawamura A
    BMC Ophthalmol; 2020 Mar; 20(1):89. PubMed ID: 32143675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the disodium salt of ethylenediaminetetraacetate on the healing of experimental suppurative wounds].
    Levenets AA; Shuvalov SM; Poliakov AV
    Stomatologiia (Mosk); 1989; 68(5):14-6. PubMed ID: 2511646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed microbial keratitis following radial keratotomy.
    Lu Y; Snibson GR
    Aust N Z J Ophthalmol; 1997 Aug; 25(3):231-2. PubMed ID: 9296299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
    Melki SA; Safar A; Yaghouti F; Scharper P; Scharper M; Zeligs B; MacDowell AL; Goldberg MA; Lustbader J
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):459-62. PubMed ID: 10901479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
    Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposits of topical norfloxacin in the treatment of bacterial keratitis.
    Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J
    Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit.
    Sloop GD; Moreau JM; Conerly LL; Dajcs JJ; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):385-91. PubMed ID: 9950597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed onset and recurrent Alcaligenes xylosoxidans keratitis.
    Pan TH; Heidemann DG; Dunn SP; Chow CY; Gossage D
    Cornea; 2000 Mar; 19(2):243-5. PubMed ID: 10746461
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.
    Hume EB; Dajcs JJ; Moreau JM; O'Callaghan RJ
    Infect Immun; 2000 Oct; 68(10):6052-5. PubMed ID: 10992521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus corneal virulence in a new topical model of infection.
    Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.